Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation - PubMed (original) (raw)

Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation

E Germain et al. Int J Cancer. 1998.

Abstract

Exogenous polyunsaturated fatty acids modulate the cytotoxic activity of anti-cancer drugs. In this study, we examined whether lipid peroxidation is a potential mechanism through which fatty acids enhance drug cytotoxicity. We measured cell viability in the human breast cancer cell line MDA-MB-231 exposed to doxorubicin in the presence of non-cytotoxic concentrations of various polyunsaturated fatty acids for 6 days. To determine the role of lipid peroxidation, the hydroperoxide level was measured in cell extracts. Among all polyunsaturated fatty acids tested, docosahexaenoic acid (DHA, 22:6n-3) was the most potent in increasing doxorubicin cytotoxicity: cell viability decreased from 54% in the presence of 10(-7) M doxorubicin alone to 21% when cells were incubated with doxorubicin and DHA. After addition of an oxidant system (sodium ascorbate/2-methyl-1,4-naphthoquinone) to cells incubated with doxorubicin and DHA, cell viability further decreased to 12%. Cell hydroperoxides increased commensurately. The effect of DHA on doxorubicin activity and lipid hydroperoxide formation was abolished by a lipid peroxidation inhibitor (dl-alpha-tocopherol) or when oleic acid (a non-peroxidizable fatty acid) was used in place of DHA. No effect was observed with mitoxantrone, a drug with a low peroxidation-generating potential. Thus, DHA may increase the efficacy of oxyradical-producing drugs through a mechanism involving a generation of lipoperoxides. This may lead in vivo to a modulation of tumor cell chemosensitivity by DHA and oxidant agents.

PubMed Disclaimer

Cited by

Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway.
Sun H, Hu Y, Gu Z, Owens RT, Chen YQ, Edwards IJ. Sun H, et al. Carcinogenesis. 2011 Oct;32(10):1518-24. doi: 10.1093/carcin/bgr132. Epub 2011 Jul 18. Carcinogenesis. 2011. PMID: 21771724 Free PMC article.
A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression.
Newell M, Baker K, Postovit LM, Field CJ. Newell M, et al. Int J Mol Sci. 2017 Aug 17;18(8):1784. doi: 10.3390/ijms18081784. Int J Mol Sci. 2017. PMID: 28817068 Free PMC article. Review.
Combination of unsaturated fatty acids and ionizing radiation on human glioma cells: cellular, biochemical and gene expression analysis.
Antal O, Hackler L Jr, Shen J, Mán I, Hideghéty K, Kitajka K, Puskás LG. Antal O, et al. Lipids Health Dis. 2014 Sep 2;13:142. doi: 10.1186/1476-511X-13-142. Lipids Health Dis. 2014. PMID: 25182732 Free PMC article.
Dietary n-3 polyunsaturated fatty acids and oxidants increase rat mammary tumor sensitivity to epirubicin without change in cardiac toxicity.
Germain E, Lavandier F, Chajès V, Schubnel V, Bonnet P, Lhuillery C, Bougnoux P. Germain E, et al. Lipids. 1999;34 Suppl:S203. doi: 10.1007/BF02562290. Lipids. 1999. PMID: 10419150 No abstract available.
Contribution of n-3 Long-Chain Polyunsaturated Fatty Acids to the Prevention of Breast Cancer Risk Factors.
Fodil M, Blanckaert V, Ulmann L, Mimouni V, Chénais B. Fodil M, et al. Int J Environ Res Public Health. 2022 Jun 28;19(13):7936. doi: 10.3390/ijerph19137936. Int J Environ Res Public Health. 2022. PMID: 35805595 Free PMC article. Review.

Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation - PubMed (original) (raw)